Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proterial, formerly known as Hitachi Metals, is a global leader in high-performance materials and components, with a significant presence in the healthcare and medical device sectors. The company specializes in advanced materials for diagnostic imaging, such as MRI magnets, and precision components for minimally invasive surgical tools, including catheters and endoscopes. Following its acquisition by a consortium led by Bain Capital in 2022, the company rebranded to Proterial to reflect its focus on professional materials science. Their medical portfolio includes specialty steels, medical-grade tubing, and high-precision wires designed to meet the rigorous demands of the life sciences industry. Proterial operates as a critical supplier to major medical device OEMs, providing the foundational technologies required for modern diagnostic and therapeutic equipment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hitachi Metals.